Packaging is where a pharmaceutical product meets the market - and every market has its own regulatory, clinical and commercial requirements. Taj Pharma offers extensive packaging customisation for DEFRATAJ while maintaining full stability and quality-system control.
Primary Packaging Options #
- PVC/PVDC-Aluminium blister - default for most export markets
- Aluminium-Aluminium (cold-form) blister - for high-humidity markets or high-sensitivity requirements
- HDPE bottle with induction seal, child-resistant closure and desiccant - for tender and multi-dose dispensing
- Custom blister cavity counts (e.g. 7, 10, 14, 15, 28 cavities)
- Unit-dose blister for hospital programmes
Secondary Packaging Options #
- Custom carton sizes matching pack counts
- Buyer branding / co-branding / private label
- Multilingual leaflet (EN / FR / PT / ES / AR; others on request)
- Tamper-evident seals
- Adherence calendar co-pack on request
- Serialisation-ready coding (GS1 DataMatrix + human-readable)
Artwork Process #
- Brief - buyer provides regulatory-approved content and brand assets
- Draft - our artwork team prepares pre-press files within ~10 business days
- Review - buyer / local regulatory approval
- Pre-production proof - printed proof approved before bulk print
- Production - artwork locked into batch record; deviations tracked
Regulatory Alignment #
All custom packaging variants are supported by stability data on the specific pack configuration intended for marketing, and are included in the CTD dossier Module 3.2.P.7. Post-approval changes are filed as Type IA / IB / II variations as appropriate.
Minimum Order Quantities #
Custom artwork or pack-size setups carry an MOQ to justify tooling and artwork investment. Indicative MOQs are shared under CDA and are typically recoverable within the first 12 months of committed supply.
Not All Pack Sizes May Be Marketed #
Availability of any given pack size or configuration in a market is subject to local registration status and supply agreements.